Identification of selective inhibitors of VHSV from biased combinatorial libraries of N,N′-disubstituted 2,5-piperazinediones

Antiviral Research

Volumn 72, Issue 2, 2006, Pages 107-115

  Mas, V ^a   Falco, A ^a   Brocal, I ^a   Perez, L ^a   Coll, J M ^b   Estepa, A ^a  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^b INIA   (Spain)

Author keywords

Antivirals; Combinatorial libraries; Inhibitors; Piperazinediones; Rhadovirus; VHSV

Indexed keywords

2,5 PIPERAZINEDIONE DERIVATIVE; N (2,4 DICHLOROPHENETHYL) N' [2 (PYRROLIDIN 1 YL)ETHYL]PIPERAZINE 2,5 DIONE; N [3 (2 METHYLPIPERIDIN 1 YL)PROPYL] N' (3,3 DIPHENYLPROPYL)PIPERAZINE 2,5 DIONE; PIPERAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL SPREADING; COMBINATORIAL LIBRARY; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG DESIGN; ECONOMIC ASPECT; FISH; INHIBITION KINETICS; LIFE CYCLE; NONHUMAN; PRIORITY JOURNAL; RHABDOVIRUS; VIRAL HEMORRHAGIC SEPTICEMIA VIRUS; VIRUS INFECTIVITY; VIRUS INHIBITION;

ANTIVIRAL AGENTS; COMBINATORIAL CHEMISTRY TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; NOVIRHABDOVIRUS; PIPERAZINES; VIRAL PROTEINS; VIRUS ASSEMBLY;

RHABDOVIRIDAE; SALMONIDAE; VIRAL HEMORRHAGIC SEPTICEMIA VIRUS;

EID: 33748323057     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2006.04.005     Document Type: Article

References (45)

1. Basurco B., and Coll J.M. Spanish isolates and reference strains of viral haemorrhagic septicaemia virus shown similar protein size patterns. Bull. Eur. Assoc. Fish Pathol. 9 (1989) 92-95
2. Basurco B., Sanz F., Estepa A., Barrera J., and Coll J.M. La septicemia hemorrágica viral de la trucha: modelo para estudios de vacunación por subunidades. Biotecnología 5 (1989) 8-11
3. Boggiano C., Reixach N., Pinilla C., and Blondelle S.E. Successful identification of novel agents to control infectious diseases from screening mixture-based peptide combinatorial libraries in complex cell-based bioassays. Biopolymers 71 2 (2003) 103-116
4. Carbonell T., Masip I., Sanchez-Baeza F., Delgado M., Araya E., Llorens O., Corcho F., Perez J.J., Perez-Paya E., and Messeguer A. Identification of selective inhibitors of acetylcholinesterase from a combinatorial library of 2,5-piperazinediones. Mol. Divers. 5 (2000) 131-143
5. Das S.C., and Pattnaik A.K. Role of the hypervariable hinge region of phosphoprotein P of vesicular stomatitis virus in viral RNA synthesis and assembly of infectious virus particles. J. Virol. 79 (2005) 8101-8112
6. Eckert D., Malashkevich V.N., Hong L.H., Carr P.A., and Kim P. Inhibiting HIV-1 entry: discovery of d-peptide inhibitors that target the gp41 coiled-coil pocket. Cell (1999) 99
7. Eckert D.M., and Kim P.S. Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region. PNAS 98 (2001) 11187-11192
8. Einholm A.P., Pedersen K.E., Wind T., Kulig P., Overgaard M.T., Jensen J.K., Bodker J.S., Christensen A., Charlton P., and Andreasen P.A. Biochemical mechanism of action of a diketopiperazine inactivator of plasminogen activator inhibitor-1. Biochem. J. 373 (2003) 723-732
9. Fdhila, F., Sanchez, J.L., Riguera, R., 2002. Patent application P200201537, Spain.
10. Fdhila F., Vazquez V., Sanchez J.L., and Riguera R. dd-Diketopiperazines: antibiotics active against Vibrio anguillarum isolated from marine bacteria associated with cultures of Pecten maximus. J. Nat. Prod. 66 (2003) 1299-1301
11. Fernandez-Alonso M., Lorenzo G., Perez L., Bullido R., Estepa A., Lorenzen N., and Coll J.M. Mapping of linear antibody epitopes of the glycoprotein of VHSV, a salmonid rhabdovirus. Dis. Aquat. Organ. 34 (1998) 167-176
12. Ferrer M., Kapoor T.M., Strassmaier T., Weissenhorn W., Skehel J.J., Oprian D., Schreiber S.L., Wiley D.C., and Harrison S.C. Selection of gp41-mediated HIV-1 cell entry inhibitors from biased combinatorial libraries of non-natural binding elements. Nat. Struct. Biol. 6 10 (1999) 953-996
13. Fijan N., Sulimanovic D., Bearzotti M., Mizinic D., Zwillenberg L.O., Chilmonczyk S., Vautherot J.F., and de Kinkelin P. Some properties of the Epithelioma papulosum cyprini (EPC) cell line from carp Cyprinus carpio. Ann. Virol. 134 (1983) 207-220
14. Frecer V., Burello E., and Miertus S. Combinatorial design of nonsymmetrical cyclic urea inhibitors of aspartic protease of HIV-1. Bioorg. Med. Chem. 13 (2005) 5492-5501
15. Green T.J., Macpherson S., Qiu S., Lebowitz J., Wertz G.W., and Luo M. Study of the assembly of vesicular stomatitis virus N protein: role of the P protein. J. Virol. 74 (2000) 9515-9524
16. Hochgurtel M., Kroth H., Piecha D., Hofmann M.W., Nicolau C., Krause S., Schaaf O., Sonnenmoser G., and Eliseev A.V. Target-induced formation of neuraminidase inhibitors from in vitro virtual combinatorial libraries. PNAS 99 (2002) 3382-3387
17. Horne W.S., Wiethoff C.M., Cui C., Wilcoxen K.M., Amorin M., Ghadiri M.R., and Nemerow G.R. Antiviral cyclic d,l-alpha-peptides: targeting a general biochemical pathway in virus infections. Bioorg Med. Chem. 13 (2005) 5145-5153
18. Hwang S., Tamilarasu N., Kibler K., Cao H., Ali A., Ping Y.H., Jeang K.T., and Rana T.M. Discovery of a small molecule Tat-trans-activation-responsive RNA antagonist that potently inhibits human immunodeficiency virus-1 replication. J. Biol. Chem. 278 (2003) 39092-39103
19. Jiang S., Lin K., Strick N., and Neurath A. Inhibition of HIV-1 infection by a fusion domain binding peptide from the HIV-1 envelope glycoprotein gp41. Biochem. Biophys. Res. Commun. 195 (1993) 533-538
20. Judice J.K., Tom J.Y., Huang W., Wrin T., Vennari J., Petropoulos C.J., and McDowell R.S. Inhibition of HIV type 1 infectivity by constrained alpha-helical peptides: implications for the viral fusion mechanism. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 13426-13430
21. Kilby J.M., Hopkins S., Venetta T.M., DiMassimo B., Cloud G.A., Lee J.Y., Alldredge L., Hunter E., Lambert D., Bolognesi D., Matthews T., Johnson M.R., Nowak M.A., Shaw G.M., and Saag M.S. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nat. Med. 4 11 (1998) 1302-1307
22. Kliger Y., Gallo S.A., Peisajovich S.G., Munoz-Barroso I., Avkin S., Blumenthal R., and Shai Y. Mode of action of an antiviral peptide from HIV-1. inhibition at a post-lipid mixing stage. J. Biol. Chem. 276 (2001) 1391-1397
23. La Ferla F.M., and Peluso R.W. The 1:1 N-NS protein complex of vesicular stomatitis virus is essential for efficient genome replication. J. Virol. 63 (1989) 3852-3857
24. Lambert D.M., Barney S., Lambert A.L., Guthrie K., Medinas R., Davis D.E., Bucy T., Erickson J., Merutka G., and Petteway S.R. Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 2186-2191
25. LeBerre M., De Kinkelin P., and Metzger A. Identification sérologique des rhabdovirus des salmonidés. Bull. Office Int. Epizooties 87 (1977) 391-393
26. Lorenzo G., Estepa A., and Coll J.M. Fast neutralization/immunoperoxidase assay for viral haemorrhagic septicemia with anti-nucleoprotein monoclonal antibody. J. Virol. Methods 58 (1996) 1-6
27. Maillard A., Domanski M., Brunet P., Chaffotte A., Guittet E., and Gaudin Y. Spectroscopic characterization of two peptides derived from the stem of rabies virus glycoprotein. Virus Res. 93 (2003) 151-158
28. Mas V., Perez L., Encinar J.A., Pastor M.T., Rocha A., Perez-Paya E., Ferrer-Montiel A., Gonzalez Ros J.M., Estepa A., and Coll J.M. Salmonid viral haemorrhagic septicaemia virus: fusion-related enhancement of virus infectivity by peptides derived from viral glycoprotein G or a combinatorial library. J. Gen. Virol. 83 (2002) 2671-2681
29. Micol V., Caturla N., Perez-Fons L., Mas V., Perez L., and Estepa A. The olive leaf extract exhibits antiviral activity against viral haemorrhagic septicaemia rhabdovirus (VHSV). Antiviral Res. 66 (2005) 129-136
30. Nefzi A., Dooley C., Ostresh J.M., and Houghten R.A. Combinatorial chemistry: from peptides and peptidomimetics to small organic and heterocyclic compounds. Bioorg. Med. Chem. Lett. 8 (1998) 2273-2278
31. Park S.H., and Raines R.T. Genetic selection for dissociative inhibitors of designated protein-protein interactions. Nat. Biotechnol. 18 (2000) 847-851
32. Perez L., Mas V., Coll J., and Estepa A. Enhanced detection of viral hemorrhagic septicemia virus (a salmonid rhabdovirus) by pretreatment of the virus with a combinatorial library-selected peptide. J. Virol. Methods 106 (2002) 17-23
33. Rinnova M., Hradilek M., Barinka C., Weber J., Soucek M., Vondrasek J., Klimkait T., and Konvalinka J. A picomolar inhibitor of resistant strains of human immunodeficiency virus protease identified by a combinatorial approach. Arch. Biochem. Biophys. 382 (2000) 22-30
34. Sanz F., and Coll J.M. Detection of viral haemorrhagic septicemia virus by direct immunoperoxidase with selected anti-nucleoprotein monoclonal antibody. Bull. Eur. Assoc. Fish Pathol. 12 (1992) 116-119
35. Singh S.B., and Green T.J. Synthesis of natural flutimide and analogous fully substituted pyrazine-2,6-diones, endonuclease inhibitors of influenza virus. J. Org. Chem. 66 16 (2001) 5504-5516
36. Srivastava P., Schito M., Fattah R.J., Hara T., Hartman T., Buckheit Jr. R.W., Turpin J.A., Inman J.K., and Appella E. Optimization of unique, uncharged thioesters as inhibitors of HIV replication. Bioorg Med. Chem. 12 (2004) 6437-6450
37. Subasinghe R.P. Epidemiological approach to aquatic animal health management: opportunities and challenges for developing countries to increase aquatic production through aquaculture. Prev. Vet. Med. 67 (2005) 117-124
38. Szardenings A.K., Harris D., Lam S., Shi L., Tien D., Wang Y., Patel D.V., Navre M., and Campbell D.A. Rational design and combinatorial evaluation of enzyme inhibitor scaffolds: identification of novel inhibitors of matrix metalloproteinases. J. Med. Chem. 41 13 (1988) 2194-2200
39. Tomassini J., Davies M., Hastings J., Lingham R., Mojena M., Raghoobar S., Singh S., Tkacz J., and Goetz M. A novel antiviral agent which inhibits the endonuclease of influenza viruses. Antimicrob. Agents Chemother. 40 (1996) 1189-1193
40. Trottier Jr. M.D., Palian B.M., and Shoshkes Reiss C. VSV replication in neurons is inhibited by type I IFN at multiple stages of infection. Virology 333 (2005) 215-225
41. Tsang S.K., Cheh J., Isaacs L., Joseph-McCarthy D., Choi S.-K., Pevear D.C., Whitesides G.M., and Hogle J.M. A structurally biased combinatorial approach for discovering new anti-picornaviral compounds. Chem. Biol. 8 (2001) 33-45
42. Wild C., Greenwell T., and Matthews T. A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus-mediated cell-cell fusion. AIDS Res. Human Reroviruses 9 (1993) 1051-1053
43. Wild T.F., and Buckland R. Inhibition of measles virus infection and fusion with peptides corresponding to the leucine zipper region of the fusion protein. J. Gen. Virol. 78 (1997) 107-111
44. Yao Q., and Compans R.W. Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection. Virology 223 (1996) 103-112
45. Yao Y., Ghosh K., Epand R.F., Epand R.M., and Ghosh H.P. Membrane fusion activity of vesicular stomatitis virus glycoprotein G is induced by low pH but not by heat or denaturant. Virology 310 (2003) 319-332